Canalys:印度首季智能手機出貨量升12% 小米(01810.HK)市佔30.6%居首位
調查機構Canalys發表的報告指,今年首季印度智能手機市場表現理想,雖然受疫情影響,三月尾開始全國推封鎖措施,但期內出貨量仍按年增12%至3,350萬台,當中小米市場份額達30.6%,出貨量1,030萬台,按年增8.4%,而Vivo則擊敗三星成為市佔第二大的品牌,出貨量按年增48.9%至670萬台,三星出貨量則按年跌13.7%至630萬台。
該行估計今年次季印度出貨量將下跌,主要因為當地的鎖國措施將直至5月3日,而廠商短期內將面對供求方面的問題,而針對人手方面的防疫措施將拖慢當地工廠的復工進度,同時亦會直接影響產能;而消費者需求方面,該行估計將維持強勁,線上渠道相信將成贏家。(el/) ~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.